CD52 and neoplasm: CD52, a glycoprotein highly expressed on lymphocytes and dendritic cells, may facilitate immune cell interactions within the tumor microenvironment (TME) or modulate immune synapse formation during antigen presentation (56), potentially influencing the efficiency of ICD-induced immune responses in UCEC.